Single-Cell Analysis of Inflammation

Sponsor: Chan Zuckerberg Initiative

Award: Applicants can request up to $175,000 in total costs per lab.

Due Date: November 19, 2019, by 5 p.m.

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) (PAR-19-376)

Sponsor: National Institutes of Health

Due Date: November 19, 2019; September 24, 2020.

Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) (PAR-19-374)

Sponsor: National Institute on Aging

Due Date: Standard dates apply. The first standard due date for this FOA is January 25, 2020. All applicants are due by 5 p.m. local time of applicant organization.

Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed) (PAR-19-366)

Sponsor: National Institute of General Medical Sciences

Due Date: November 13, 2019; October 1, 2020; October 1, 2021. All applications are due by 5 p.m. local time of applicant organization.

Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed) (RFA-HL-20-006)

Sponsor: National Institutes of Health

Due Date: November 18, 2019; October 15, 2020; October 15, 2021, by 5 p.m. local time of applicant organization.

MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed) (RFA-AG-20-032)

Sponsor: National Institute on Aging

Award: NIA intends to commit $777,000 in direct costs in FY 2020 to fund four awards.

Due Date: October 28, 2019 No late applications will be accepted for this funding opportunity announcement.

2020 Michelson Prizes

Award: $150K Awards for Young Investigators

Due Date: Deadline for submission is October 31, 2019.

Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed) (RFA-HL-20-021)

Sponsor: National Heart, Lung, and Blood Institute

Award: NHLBI intends to commit total costs of up to $1,100,000 in FY 2020, $4,400,000 in FY 2021, $4,400,000 in FY 2022, $4,400,000 in FY 2023, $4,400,000 in FY 2024 and $3,300,000 in FY 2025.

Due Date: December 2, 2019; October 19, 2020

Mechanistic Basis of TDP-43-dependent Pathobiology in Common Dementias (R01 Clinical Trial not Allowed) (RFA-NS-20-005)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Award: NINDS intends to commit $6,750,000 in FY 2020 to fund eight to 10 awards.

Due Date: ): November 15, 2019 by 5 p.m. local time of applicant organization.

Peripheral Pathology in the Lewy Body Dementias (R01 Clinical Trial Not Allowed) (RFA-NS-20-014)

Sponsor: National Institute of Neurological Disorders and Stroke; National Institute on Aging

Award: NINDS intends to commit $3,750,000 in FY 2020 to fund five awards.

Due Date: The due date for this FOA is December 3, 2019.

January 2020 International Research Grant Program

Sponsor: Alzheimer's Association

Award: $150,000 to $175,000

Due Date: LOI deadline: September 30, 2019, 5 p.m.

Alzheimer's Disease and Related Dementias - 2020 - 2021 Development Project

Sponsor: UW Alzheimer's Disease Research Center

Award: UW Alzheimer's Disease Research Center

Due Date: LOI: September 16, 2019. Application deadline: November 15, 2019.

The Tau Pipeline Enabling Program (T-PEP)

Sponsor: Alzheimer's Association and Tau Consortium

Award: Up to $750,000

Due Date: LOI Deadline: September 12, 2019, 5 p.m. ET

Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) (RFA-HL-20-030)

Sponsor: National Institutes of Health

Award: NIH intends to commit total costs of up to $3,118,000 in fiscal 2020. These funds are anticipated to fund up to five new awards in fiscal 2020.

Due Date: October 18, 2019 No late applications will be accepted for this Funding Opportunity Announcement.

Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) (PAR-19-342)

Sponsor: National Institute of General Medical Sciences

Due Date: November 15, 2019; November 2, 2020, by 5 p.m. local time of applicant organization.